Mustang Bio Inc. (MBIO)
Mustang Bio Statistics
Share Statistics
Mustang Bio has 2.76M shares outstanding. The number of shares has increased by 369.38% in one year.
| Shares Outstanding | 2.76M |
| Shares Change (YoY) | 369.38% |
| Shares Change (QoQ) | 34.03% |
| Owned by Institutions (%) | 8.04% |
| Shares Floating | 2.07M |
| Failed to Deliver (FTD) Shares | 33.16K |
| FTD / Avg. Volume | 10.56% |
Short Selling Information
The latest short interest is 37.02K, so 2.86% of the outstanding shares have been sold short.
| Short Interest | 37.02K |
| Short % of Shares Out | 2.86% |
| Short % of Float | 3.31% |
| Short Ratio (days to cover) | 0.08 |
Valuation Ratios
The PE ratio is -11.25 and the forward PE ratio is -0.24. Mustang Bio's PEG ratio is 0.24.
| PE Ratio | -11.25 |
| Forward PE | -0.24 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | 4721.76 |
| P/FCF Ratio | -11.71 |
| PEG Ratio | 0.24 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Mustang Bio Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.74, with a Debt / Equity ratio of 20.31.
| Current Ratio | 0.74 |
| Quick Ratio | 0.74 |
| Debt / Equity | 20.31 |
| Total Debt / Capitalization | 95.31 |
| Cash Flow / Debt | -19.81 |
| Interest Coverage | -38.6 |
Financial Efficiency
Return on equity (ROE) is -419.53% and return on capital (ROIC) is -1935.37%.
| Return on Equity (ROE) | -419.53% |
| Return on Assets (ROA) | -2.91% |
| Return on Capital (ROIC) | -1935.37% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -645.02K |
| Employee Count | 80 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -97.01% in the last 52 weeks. The beta is 1.72, so Mustang Bio's price volatility has been higher than the market average.
| Beta | 1.72 |
| 52-Week Price Change | -97.01% |
| 50-Day Moving Average | 5.87 |
| 200-Day Moving Average | 12.38 |
| Relative Strength Index (RSI) | 25.72 |
| Average Volume (20 Days) | 313.9K |
Income Statement
| Revenue | n/a |
| Gross Profit | -2.23M |
| Operating Income | -50.73M |
| Net Income | -51.6M |
| EBITDA | -48.06M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -6 |
Balance Sheet
The company has 6.23M in cash and 2.5M in debt, giving a net cash position of 3.74M.
| Cash & Cash Equivalents | 6.23M |
| Total Debt | 2.5M |
| Net Cash | 3.74M |
| Retained Earnings | -380.97M |
| Total Assets | 7.19M |
| Working Capital | -8.98M |
Cash Flow
In the last 12 months, operating cash flow was -49.48M and capital expenditures -114K, giving a free cash flow of -49.59M.
| Operating Cash Flow | -49.48M |
| Capital Expenditures | -114K |
| Free Cash Flow | -49.59M |
| FCF Per Share | -5.76 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MBIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -301.51% |
| FCF Yield | -904.35% |
Analyst Forecast
The average price target for MBIO is $100, which is 4925.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $100 |
| Price Target Difference | 4925.1% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Apr 4, 2023. It was a backward split with a ratio of 1:15.
| Last Split Date | Apr 4, 2023 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -88.58 |
| Piotroski F-Score | 2 |